Inflammatory bowel diseases and the risk of adverse health outcomes: Umbrella review of meta-analyses of observational studies
Authors:
- 1 July 2021
- journal article
- review article
- Published by Elsevier in Digestive and Liver Disease
- Vol. 53 (7) , 809-816
Abstract
No abstract availableKeywords
Funding Information
- Sichuan Provincial Science and Technology Support Program (2018SZ0189)
This publication has 56 references indexed in Scilit:
- Chronic ulcerative colitis and colorectal cancerCancer Letters, 2014
- GRADE guidelines: 1. Introduction—GRADE evidence profiles and summary of findings tablesJournal of Clinical Epidemiology, 2011
- C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysisThe Lancet, 2010
- AMSTAR is a reliable and valid measurement tool to assess the methodological quality of systematic reviewsJournal of Clinical Epidemiology, 2009
- Association of Carotid Artery Intima-Media Thickness, Plaques, and C-Reactive Protein With Future Cardiovascular Disease and All-Cause MortalityCirculation, 2007
- The Risk of Cancer in Patients with Crohn's DiseaseDiseases of the Colon & Rectum, 2007
- Meta‐analysis: mortality in Crohn’s diseaseAlimentary Pharmacology & Therapeutics, 2007
- A meta-analysis on the influence of inflammatory bowel disease on pregnancyGut, 2006
- Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurineGut, 2005
- Outcome of Pregnancy in Women Receiving Infliximab for the Treatment of Crohn's Disease and Rheumatoid ArthritisAmerican Journal of Gastroenterology, 2004